Evolution

IP as Architecture

Building a Portfolio That Protects Your Position

Overview

Intellectual property is not a collection of filings. It is a structure, and like any structure it either holds weight or it does not. A portfolio can look substantial on paper and protect nothing that matters, because the claims are narrow, the disclosure came too early, or the thing competitors actually need was never protected at all. This evolution teaches you to design intellectual property as architecture: what to protect, what to hold as a secret, what to leave alone, and how the whole assembly performs when an investor or an acquirer examines it.

Format

Online

Items

Duration

5-7 hours

Recommended for

Inventors building a first patent position
Physician-founders negotiating with technology transfer
Founders deciding between patent and trade secret
Teams preparing for investor or acquirer diligence
Researchers approaching publication or presentation
Advisors assessing portfolio strength

THE LEARNING FRAMEWORK

The learning framework

The portfolio that protected the wrong thing

A company holds a granted patent on its device. The claims cover the mechanism the founders spent three years developing, and they are proud of it, correctly, because the engineering was hard. An acquirer runs diligence. Their counsel reads the claims and concludes that the mechanism can be designed around in about a year, while the thing that would actually be difficult to replicate, the manufacturing process that makes the device economical at volume, was never protected in any form. It was described in a conference presentation eighteen months earlier. The technology works. The patent is valid. The company is worth substantially less than the founders expected, because the portfolio protects what they invented rather than what a competitor would need.

Why filings get mistaken for strategy

Patent prosecution is a specialist discipline and founders reasonably delegate it. The specialist drafts strong claims around the invention they are given. They are not asked, and are not usually positioned to answer, which parts of the business would be hardest for a competitor to reproduce, or whether protecting them is better served by a patent than by secrecy and contract. Three consequences follow. Disclosure happens before anyone has decided what it forecloses, and in academic settings publication and presentation pressure is constant. Trade secrets are treated as the absence of a strategy rather than as a deliberate alternative with different economics. And geographic filing is decided by budget rather than by where a competitor would manufacture or where a payer market exists. Underneath all of it sits a defect that surfaces only in diligence: a chain of assignments that does not close. Contributors who never signed, consultants working under agreements that assign nothing, improvements made after a license was granted. The portfolio can be excellent and still not be yours.

Intellectual property designed as a structure

Healthcare innovators who complete this evolution start from what creates and defends value rather than from what is patentable. They can state which parts of their business are genuinely difficult to reproduce and which form of protection fits each: patent, trade secret, contract, data, or physical control of a biological material. They understand what disclosure costs before they make it. They can read a portfolio the way an acquirer's counsel reads one, and they know where their own is thin. They negotiate with a technology transfer office knowing what a license needs to include for the portfolio to hold together.

WHAT YOU WILL LEARN

By the end of this evolution, you will be able to:

Identify what is actually worth protecting

Separate technical novelty from commercially important defensibility and identify where value actually resides in a medical innovation.

Choose the right form of protection

Determine when patents, trade secrets, software protections, data rights, trademarks, know-how, contracts, or other mechanisms are appropriate.

Time disclosure deliberately

Recognize how publications, abstracts, presentations, demonstrations, and other disclosures can affect protection strategies before rights are secured.

Assess whether patent protection meaningfully constrains competitors

Interpret claim scope at a strategic level, identify design-around opportunities, and consider whether infringement can realistically be detected and enforced.

Distinguish patent ownership from freedom to operate

Recognize third-party rights that may restrict commercialization and understand when formal FTO analysis becomes necessary.

Make geographic protection decisions strategically

Evaluate where protection matters based on customers, competitors, manufacturing, future markets, and cost rather than filing everywhere by default.

Build an IP architecture that evolves with the company

Identify how improvements, new products, software, data, indications, and future generations can shift where the company's defensible value resides.

Evaluate a portfolio through the eyes of an investor, competitor, or acquirer

Assess whether a portfolio protects commercially important territory, where it remains vulnerable, and how those strengths and weaknesses may affect financing, diligence, and strategic value.

WHY THIS MATTERS

Why this matters

Counts of filings do not move a valuation. What moves it is whether a competitor can reach the same market without infringing, and that question is answered by claim scope, not by volume.

A presentation, an abstract, a poster, or a conversation with a potential partner can foreclose protection permanently. In academic settings the pressure to disclose is constant and the consequences are rarely explained.

Some of the most valuable positions in healthcare are protected by processes never disclosed. Choosing secrecy deliberately, and building the contractual and operational structure to sustain it, is different from failing to file.

Enforcement is expensive, slow, and uncertain, and the party who can fund a multi-year dispute holds leverage the merits do not supply. A position that depends entirely on litigation you may not be able to afford is a common and expensive error, and it should change what you file and what you protect by other means.

Two companies with the same product and the same clinical data can be worth materially different amounts based on how their intellectual property is assembled. That difference is designed years earlier.

Recommended for

Healthcare innovators navigating:

A first patent filing or provisional

The patent and trade secret decision

Publication or conference disclosure timing

Freedom to operate assessment

Territory strategy for filing and protection

Whether a patent position can realistically be detected and enforced

Protection strategy for improvements, software, and data

Investor or acquirer diligence on intellectual property

FOR INSTITUTIONS

Faculty who understand the process move through it faster.

Academic medical centers, research universities, and health systems sponsor cohorts so that inventors arrive at the office of technology transfer prepared: complete disclosures, clean assignment records, and realistic expectations about pathway and timeline. Cohort training is available for faculty, residents, and research staff, with CME.

Learn more about institutional cohorts →

HOW TO GET STARTED

How to get started

Your path to becoming a Certified Professional Entrepreneur

1st Step

Reserve your seat

Your deposit reserves a place in the cohort. Twenty seats. No application, no admissions committee, no waiting on a decision.

2nd Step

Begin the evolutions

Structured online learning you work through on your own schedule. Lectures run under fifteen minutes. Each evolution carries reading, supporting material, working tools, and case studies drawn from real transactions.

3rd Step

Join the live sessions

Live discussion sessions on Zoom, facilitated by Chris and Christos. Not recorded. This is where the material meets your actual situation, and where the cohort becomes a network.

EXPAND YOUR KNOWLEDGE